Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Alex Mann is a senior clinical scientist with over 25 years’ experience working in infectious and respiratory disease clinical research at hVIVO.
He has significant expertise in leading the design, execution, and analysis of human challenge studies for efficacy testing, using pathogens such as Influenza, RSV, and Rhinovirus, as well as more recently clinically characterising new challenge agents such as HMPV and SARS-Cov2 variants.
A major focus of Alex's research has also been collaborating with partners to mature hVIVO’s challenge and non-challenge airway disease capabilities including for asthma, COPD, bronchiectasis.
No articles found for this topic.
